Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?

• Main Authors: Janine A. van Til (Author), Michelle M. A. Kip (Author), Ellen J. H. Schatorjé (Author), Gillian Currie (Author), Marinka Twilt (Author), Susanne M. Benseler (Author), Joost F. Swart (Author), Sebastiaan J. Vastert (Author), Nico Wulffraat (Author), Rae S. M. Yeung (Author), C. G. M. (Karin) (Author), Sanne Warta (Author), Deborah A. Marshall (Author), Maarten J. IJzerman (Author), on behalf of the UCAN CAN-DU, UCAN CURE consortia (Author)
• Format: Book
• Published: BMC, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Objective Approximately one third of children with JIA receive biologic therapy, but evidence on biologic therapy withdrawal is lacking. This study aims to increase our understanding of whether and when pediatric rheumatologists postpone a decision to withdraw biologic therapy in children w...